The DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Cytokines IL-1 β, IL-6, and TNF- α Enhance In Vitro Growth of Bacteria
Abstract
We have previously reported that in acute respiratory distress syndrome (ARDS), nonsurvivors have persistent elevation in pulmonary and circulating proinflammatory cytokine levels over time and a high rate of nosocomial infections antemortem. In these patients, none of the proven or suspected nosocomial infections caused a transient or sustained increase in plasma proinflammatory cytokine levels above preinfection values. We hypothesized that cytokines secreted by the host during ARDS may favor the growth of bacteria. We conducted an in vitro study of the growth of three bacteria clinically relevant in nosocomial infections, evaluating their in vitro response to various concentrations of tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6. We found that all three bacterial species showed concentration-dependent growth enhancement when incubated with one or more tested cytokines and that blockade by specific neutralizing cytokine MoAb significantly inhibited cytokine-induced growth. When compared with control, the 6-h growth response (cfu/ml) was maximal with IL-1beta at 1,000 pg for Staphylococcus aureus (36 +/- 16 versus 377 +/- 16; p = 0.0001) and Acinetobacter spp. (317 +/- 1,147 versus 1,124 +/- 147; p = 0.002) and with IL-6 at 1,000 pg for Pseudomonas aeruginosa (99 +/- 50 versus 509 +/- 50; p = 0.009). The effects of cytokines were seen only with fresh isolates and were lost with passage in vitro on bacteriologic medium without added cytokines. In this study we provide additional evidence for a newly described pathogenetic mechanism for bacterial proliferation in the presence of exaggerated and protracted inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Almost every common clinical intervention used in intensive care (eg, enteral feeding,43 proton-pump inhibitors,38,39 systemic catecholamines,22,23 and systemic antibiotics65,66) changes environmental growth conditions for intestinal bacteria”
From The microbiome and critical illness (2016) · cites this paper as [23]
In the citing paper
“The normally nutrient-poor environment of the alveolus is flooded with nutrient-rich oedema,55 pockets of oxygen and heterogeneous temperature gradients are established,48,49 and the signalling molecules of the host stress response selectively promote the growth of potential pathogens.”
From The microbiome and critical illness (2016) · cites this paper as [23]
In the citing paper
“as well as catecholamines, growth promotion is seen with TNFα, interleukins 1, 6, and 8, and glucocorticoids.”
From The microbiome and critical illness (2016) · cites this paper as [23]
Citations
Cites
Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907
Persistent Elevation of Inflammatory Cytokines Predicts a Poor Outcome in ARDS
Meduri, G. U., Headley, S., Kohler, G., Stentz, F. B., Tolley, E. A., Umberger, R. A., & Leeper, K. V. (1995) · CHEST Journal · doi:10.1378/chest.107.4.1062 · Cited by 788
Inflammatory Cytokines in the BAL of Patients With ARDS
Meduri, G. U., Kohler, G., Headley, S., Tolley, E., Stentz, F., & Postlethwaite, A. (1995) · Chest · doi:10.1378/chest.108.5.1303 · Cited by 695
Self-citationGrowth characteristics of group A streptococci in a new chemically defined medium
Rijn, I. V. D., & KESSLER, R. E. (1980) · Infection and Immunity · doi:10.1128/iai.27.2.444-448.1980 · Cited by 484
Evaluation of Bronchoscopic Techniques for the Diagnosis of Nosocomial Pneumonia
Chastre, J. E., Fagon, J.-Y., Lecsö‐Bornet, M., Calvat, S., Dombret, M.-C., Khani, R., Basset, F., & Gibert, C. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599829 · Cited by 362
Broug-Holub, E., Toews, G. B., van Iwaarden, J. F., Strieter, R. M., Kunkel, S. L., Paine, R., & Standiford, T. J. (1997) · Infection and Immunity · doi:10.1128/iai.65.4.1139-1146.1997 · Cited by 263
Infections and the Inflammatory Response in Acute Respiratory Distress Syndrome
Headley, A. S., Meduri, G. U., & Tolley, E. A. (1997) · CHEST Journal · doi:10.1378/chest.111.5.1306 · Cited by 259
Krafft, P., Fridrich, P., Pernerstorfer, T., Fitzgerald, R. D., Koç, D., Schneider, B., Hammerle, A. F., & Steltzer, H. (1996) · Intensive Care Medicine · doi:10.1007/bf01708091 · Cited by 244
Interactions Between Neutrophils and Cytokines in Blood and Alveolar Spaces During ARDS
Chollet‐Martin, S., Jourdain, B., Gibert, C., Elbim, C., Chastre, J. E., & Gougerot‐Pocidalo, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.3.8810592 · Cited by 240
Cerami, A. (1992) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(92)90035-m · Cited by 199
Enhancement of Growth of Virulent Strains of Escherichia coli by Interleukin-1
Porat, R., Clark, B. D., Wolff, S. M., & Dinarello, C. A. (1991) · Science · doi:10.1126/science.1833820 · Cited by 188
Lower Respiratory Tract Colonization and Infection during Severe Acute Respiratory Distress Syndrome
Delclaux, C., Roupie, É., Blot, F., Brochard, L. J., Lemaire, F., & Brun‐Buisson, C. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.4.9701065 · Cited by 185
Meduri, G. (1996) · European Respiratory Journal · doi:10.1183/09031936.96.09122650 · Cited by 129
Martin, T. R., Pistorese, B. P., Hudson, L. D., & Maunder, R. J. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.2.254 · Cited by 128
Luo, G., Niesel, D. W., Shaban, R. A., Grimm, E. A., & Klimpel, G. R. (1993) · Infection and Immunity · doi:10.1128/iai.61.3.830-835.1993 · Cited by 119
Meduri, G. U., Reddy, R. C., STANLEY, T., & El-Zeky, F. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.158.3.9706112 · Cited by 109
Quantitation of maximal bactericidal capability in human neutrophils.
Clawson, C. C., & Repine, J. E. (1976) · PubMed · Cited by 84
Microorganisms and their interaction with the immune system
Kotwal, G. J. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.4.415 · Cited by 82
Specific high affinity binding of human interleukin 1β by Caf1A usher protein of Yersinia pestis
Zav'yalov, V. P., Chernovskaya, T. V., Navolotskaya, E. V., Karlyshev, A. V., MacIntyre, S., Vasiliev, A. M., & Abramov, V. M. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00878-d · Cited by 72
Pulmonary and Systemic Inflammatory Responses in Rabbits With Gram-Negative Pneumonia
Fox-Dewhurst, R., Alberts, M., Kajikawa, O., Caldwell, E., Johnson, M., Skerrett, S. J., Goodman, R. B., Ruzinski, J., Wong, V. A., Chi, E. Y., et al. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.155.6.9196112 · Cited by 61
Falkow, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119527 · Cited by 45
The pathogenesis of ventilator-associated pneumonia: II. The lower respiratory tract
Meduri, G. U., & Estes, R. J. (1995) · Intensive Care Medicine · doi:10.1007/bf01707417 · Cited by 45
Denis, M., & Gregg, E. O. (1991) · Canadian Journal of Microbiology · doi:10.1139/m91-080 · Cited by 27
Growth Responses of Coliform Bacteria to Recombinant Bovine Cytokines
Hogan, J. S., Todhunter, D. A., Smith, K. L., Schoenberger, P. S., & Sordillo, L. M. (1993) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(93)77425-1 · Cited by 15
Porat, R., Clark, B. D., Wolff, S. M., & Dinarello, C. A. (1992) · Science · doi:10.1126/science.258.5088.1562-a · Cited by 7
Research works printed but not linked: 1
- Porat, 1992, IL-1β and Escherichia coli [Letter]., Science, 258, 1562, 10.1126/science.258.5088.1562.b · DOI
Cited by
Sorted by citations
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 774
The microbiome and critical illness
Dickson, R. P. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00427-0 · Cited by 460
Acute Lower Respiratory Tract Infection
Mizgerd, J. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmra074111 · Cited by 455
Held, H., BOETTCHER, S., Hamann, L., & Uhlig, S. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.2003001 · Cited by 258
Interleukin-6 in Surgery, Trauma, and Critical Care Part II: Clinical Implications
Jawa, R. S., Anillo, S., Huntoon, K. M., Baumann, H., & Kulaylat, M. N. (2010) · Journal of Intensive Care Medicine · doi:10.1177/0885066610384188 · Cited by 233
Metadata
- Authors
- MEDURI, G. U., KANANGAT, S., STEFAN, J., TOLLEY, E., & SCHABERG, D.
- Affiliations
- Memphis VA Medical Center (US)
- ORCID
- TOLLEY, ELIZABETH
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-09-01
- Volume
- 160
- Issue
- 3
- Pages
- 961-967
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2064610856
- Cited by
- 155
- References
- 26
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 5 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 8 · 2019: 10 · 2018: 7 · 2017: 4 · 2016: 8 · 2015: 1 · 2014: 5 · 2013: 3 · 2012: 2
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- IL-1β, interleukin-6, TNF-α, inflammatory cytokines, bacterial growth enhancement, nosocomial infections, acute respiratory distress syndrome, Staphylococcus aureus, Acinetobacter, Pseudomonas aeruginosa
- MeSH terms
- Acinetobacter, Analysis of Variance, Antibodies, Monoclonal, Culture Media, Dose-Response Relationship, Drug, Interleukin-1, Pseudomonas aeruginosa, Staphylococcus aureus, Tumor Necrosis Factor-alpha, Interleukin-6, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review